{"id":"W4294001741","doi":"10.1001/jamaoncol.2022.3829","title":"Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer","year":2022,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":324,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen's University; Canadian Partnership Against Cancer; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Gemcitabine; FOLFIRINOX; Pancreatic cancer; Oncology; Internal medicine; Adjuvant; Adjuvant therapy; Cancer; Irinotecan; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003031701,0.0007386073,0.001204503,0.0003405999,0.0003061981,0.0007334006,0.0005300814,0.001076752,0.001606314],"category_scores_gemma":[0.002924344,0.0001964749,0.001693363,0.0003199159,0.0005320505,0.0007050604,0.0003087579,0.001281024,0.0001705476],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001392535,"about_ca_system_score_gemma":0.001357049,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002078385,"about_ca_topic_score_gemma":0.005077563,"domain_scores_codex":[0.9990108,0.0005769379,0.00006948446,0.00009482792,0.0001063153,0.0001416021],"domain_scores_gemma":[0.9982069,0.0005503274,0.000628439,0.00009159019,0.00008458252,0.0004382603],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9570971,0.005510011,0.007512902,0.0002978417,0.001185951,0.00003130415,0.00003883934,0.001122266,0.0009455856,0.00006187856,0.0005648569,0.02563143],"study_design_scores_gemma":[0.4383674,0.4815695,0.06913402,0.0001720552,0.003347699,0.0001368432,0.00009340676,0.003034655,0.00218091,0.0004659983,0.001444817,0.00005262119],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9941998,0.003841621,0.0001933789,0.0002399493,0.0001048523,0.0003276433,0.0003708978,0.00001709784,0.0007048374],"genre_scores_gemma":[0.9978285,0.0006504207,0.0002152776,0.0002131355,0.00009815831,0.0002164967,0.00041581,0.000002632814,0.000359558],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003031701,"threshold_uncertainty_score":0.01603335,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04120636559404846,"score_gpt":0.3980314652659258,"score_spread":0.3568250996718773,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}